<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:yandex="http://news.yandex.ru" xmlns:media="http://search.yahoo.com/mrss/" xmlns:turbo="http://turbo.yandex.ru" version="2.0">
	<channel>
		<title>Projects_laboratory_bsb</title>
		<link>https://nla.nu.edu.kz</link>
		<language>ru</language>
		<item turbo="true">
			<title>Comparative investigation and characterization of transcriptome profiles from patients with esophageal squamous cell carcinoma</title>
			<link>https://nla.nu.edu.kz/tpost/fcjkpi7gm1-comparative-investigation-and-characteri</link>
			<amplink>https://nla.nu.edu.kz/tpost/fcjkpi7gm1-comparative-investigation-and-characteri?amp=true</amplink>
			<pubDate>Tue, 26 Jul 2022 09:33:00 +0300</pubDate>
			<description>PI: Ulykbek KairovSource of funding: grant of the MSHE  of the RKProject years: 2021-2023, 36 months.IRN: AP09058660</description>
			<turbo:content>
<![CDATA[<header><h1>Comparative investigation and characterization of transcriptome profiles from patients with esophageal squamous cell carcinoma</h1></header>Esophageal cancer ranks sixth in prevalence among all types of cancer in Kazakhstan and is characterized by a low level of detection. Due to epidemiological and genetic differences between different populations, the difficulty of choosing treatment for specific groups of patients and histological forms of esophageal cancer increases. Therefore, it is necessary to study and investigate the population-specific cause of the occurrence and development of<br />esophageal cancer at the genomic, transcriptomic and proteomic levels. A comprehensive study of the molecular mechanisms (gene expression, genomic rearrangements and translocations, regulation using non-coding RNAs, functional study of fusion genes, DNA methylation, single-cell RNA sequencing) of the occurrence and progression of esophageal cancer using "omics" technologies is the key to identifying biomarkers for early diagnosis and targeted therapy. Understanding the pathogenesis of esophageal cancer will allow for more effective approaches to early diagnosis of the disease and further treatment strategies. Currently, the development of biomedicine is closely related to the development of new analysis approaches in post-"omics" research. Significant progress in the field of genomics, transcriptomics, proteomics and bioinformatics allows the use of modern technologies and methods for the comprehensive study and diagnosis of many diseases. Cancer research is one of the most important sources of large-scale molecular profiling data. An urgent task of modern bioinformatics and systems biology is the detailed study of huge arrays of "multi-<br />omics" data, which requires the use of reliable mathematical and statistical methods to search for and detect hidden signals and signaling pathways that regulate the development and functional activity of cancer cells.<br /><br /><strong>The main goal </strong>of the project is to study transcriptomic profiles of Kazakhstani patients with squamous cell esophageal cancer and to study in detail the expression of non-coding RNAs in comparison with esophageal adenocarcinoma. The results of our preliminary studies of cancer transcriptome profiles of Kazakhstani patients revealed differentially expressed genes that require additional experimental work on the validation of detected genes, validation of detected fusion genes, as well as new experimental work on the study of non-coding RNAs (microRNAs, small and long non-coding RNAs) in tumor&nbsp;tissues. It is also planned to conduct a meta-analysis of various transcriptomic datasets of esophageal cancer using Independent Components Analysis for a comparative study of reproducible molecular signals and signaling pathways.<br /><br /><strong>Tasks of the project:</strong><br />- Extraction and evaluation of the quality of RNA from tumor tissues of Kazakhstani patients with esophageal cancer will be carried out;<br />- The detection of the expression of individual genes in the tumor tissues of Kazakhstani patients with esophageal cancer using RT-PCR technology will be carried out;<br />-Previously identified fusion genes in tumor tissues of Kazakhstani patients with esophageal cancer will be evaluated using RT-PCR technology;<br />- Targeted profiling of non-coding RNAs will be carried out using next-generation sequencing technologies;<br />- Identification of non-coding RNAs in tumor tissues of Kazakhstani patients with esophageal cancer using bioinformatics methods will be carried out;<br />- Comparative meta-analysis of transcriptomic profiles using Independent Components Analysis and identification of reproducible molecular signaling pathways characteristic of esophageal cancer will be carried out;]]>
			</turbo:content>
		</item>
		<item turbo="true">
			<title>Pan-cancer deconvolution of omics data using Independent Component Analysis</title>
			<link>https://nla.nu.edu.kz/tpost/z8va1rv791-pan-cancer-deconvolution-of-omics-data-u</link>
			<amplink>https://nla.nu.edu.kz/tpost/z8va1rv791-pan-cancer-deconvolution-of-omics-data-u?amp=true</amplink>
			<pubDate>Fri, 16 Sep 2022 14:32:00 +0300</pubDate>
			<description>PI: Ulykbek KairovSource of funding: grant of the MSHE of the RKProject years: 2018-2020, 36 monthsIRN: АР05135430</description>
			<turbo:content>
<![CDATA[<header><h1>Pan-cancer deconvolution of omics data using Independent Component Analysis</h1></header><strong>The main idea</strong>&nbsp;- of the project is focused on extraction of hidden biological signals from multilevel data types (microarray / RNA-seq / ChIP-seq / scRNA-seq) obtained for tumor tissues of various types and different localizations for comprehensive analysis of tumor heterogeneity, as well as integration of biological processes ongoing in individual cancer cells and in tumor tissue.<br /><br /><strong>Aim of the project: </strong><br />Pan-cancer deconvolution of “multi-omics” data from high-throughput omics platforms using Independent Component Analysis for comprehensive meta-analysis of hidden signals and pathways.<br /><br /><strong>Tasks of the project:</strong><br /><ul><li>Creation of database with cancer datasets from “multi-omics” platforms (microarrays, RNA-seq, Chip-Seq, scRNA-seq);</li><li>Microarrays datasets processing and normalization as well as mapping and alignment of sequencing reads using bioinformatics methods;</li><li>Independent Component Analysis application for each prepared cancer dataset and calculation of optimal number of independent components;</li><li>Identification and visualization of reproducible gene interaction pathways and meta-genes specific or common for pan-cancer “multi-omics” datasets;</li><li>Development of user-friendly interface and software with developed and implemented methodology of ICA application for cancer “multi-omics” datasets;</li><li>Formation of atlas of reproducible meta-genes and interaction pathways based on the results of the project and analysis of cancer “multi-omics” datasets.</li></ul>]]>
			</turbo:content>
		</item>
		<item turbo="false">
			<link>https://nla.nu.edu.kz/tpost/97nyajvrs1-analysis-and-identification-of-kazakh-sp</link>
		</item>
		<item turbo="true">
			<title>Advanced studying the formation of stable secondary DNA structures as applied to DNA technologies</title>
			<link>https://nla.nu.edu.kz/tpost/opm6rk0zz1-advanced-studying-the-formation-of-stabl</link>
			<amplink>https://nla.nu.edu.kz/tpost/opm6rk0zz1-advanced-studying-the-formation-of-stabl?amp=true</amplink>
			<pubDate>Fri, 27 Jan 2023 08:21:00 +0300</pubDate>
			<description>PI: Ruslan Kalendar Source of funding: grant of the MSHE of the RKProject years: 2020-2022, 36 monthsIRN: AP08855353</description>
			<turbo:content>
<![CDATA[<header><h1>Advanced studying the formation of stable secondary DNA structures as applied to DNA technologies</h1></header><div class="t-redactor__text">DNA oligonucleotides are essential components of a high number of technologies in molecular biology which are based on DNA and RNA hybridization. Such DNA hybridization-based experimental methods as multiplex polymerase chain reaction, microarray analysis, NanoString multiplex analysis, next-generation targeted sequencing, and similar approaches require the use of complex mixtures of oligonucleotides (primers and probes) in one tube. Single-stranded DNA molecules also tend to bind to themselves. The probability of such nonspecific binding increases depending on the degree of analysis complexity. Moreover, there is a necessity to revise existing approaches to the development of certain hybridization probes and primers for existing DNA detection technologies. First of all, it is necessary for such technologies as standard or quantitative PCR with various DNA amplification methods for the detection of a specific amplicon using hybridization probes, as well as for isothermal DNA amplification methods that combine many nested primers and fluorescent probes. Revision is needed to accurately determine the melting temperature for both complementary DNA duplexes and DNA duplexes with the presence of non-complementary bases through the use of machine learning methods.<br /><br />The main objective of the project is to conduct study of stable secondary structures of nucleic acids based on experimental data on DNA/DNA hybridization for complex single-stranded DNA mixtures using a machine learning approach. The development of bioinformatics tools that implement machine learning approaches for calculating the basic thermodynamics of secondary DNA structures as applied to DNA detection and amplification technologies.</div>]]>
			</turbo:content>
		</item>
		<item turbo="true">
			<title>Software development and testing of targeting panels in nanopore gene sequencing for precision medicine</title>
			<link>https://nla.nu.edu.kz/tpost/j1t2t5gum1-software-development-and-testing-of-targ</link>
			<amplink>https://nla.nu.edu.kz/tpost/j1t2t5gum1-software-development-and-testing-of-targ?amp=true</amplink>
			<pubDate>Thu, 15 May 2025 13:37:00 +0300</pubDate>
			<description>AP23483529PI: Ruslan Kalendar</description>
			<turbo:content>
<![CDATA[<header><h1>Software development and testing of targeting panels in nanopore gene sequencing for precision medicine</h1></header><div class="t-redactor__text"><strong>Project goal: </strong>The aim of the project is to develop and test software for the design of targeted gene panels for long fragment sequencing using nanopore technology.</div><div class="t-redactor__text"><strong>Project description: </strong>To develop software for the design and optimization of compatible primer sets for long distance multiplex PCR for the target genes. To develop a platform for comprehensive analysis of third generation amplicon sequencing data and analysis of identified variants. Investigate and evaluate the genotyping of mutations in the BRCA1/2, KRAS, NRAS, BRAF, PIK3CA and EGFR genes in tumour samples for the identification of rare variants using a gene panel for targeted third-generation sequencing analysis with ONT. To evaluate the genotyping of mutations in key biomarker genes in tumour samples for the identification of rare variants using targeted third-generation sequencing analysis. Mutational profiles will be identified and correlated with clinical outcomes (overall response rate; progression-free survival; overall survival).</div><div class="t-redactor__text"><strong>PI</strong>: Ruslan Kalendar</div><div class="t-redactor__text"><strong>Expected results: </strong>The project will focus on the development of software for the design of gene panels using nanopore sequencing of the human genome that can be interpreted and applied by researchers and public health organizations. A diagnostic oncopanel will be developed as a precision assay based on targeted third-generation sequencing using Oxford Nanopore Technologies' genomic profiling solution to detect key biomarkers such as BRCA1/2, KRAS, NRAS, BRAF, PIK3CA and EGFR. A platform will be developed to comprehensively analyze amplicon sequencing data and analyze identified variants. A decision support tool will be used to match gene variants detected in the sequences with databases of known biomarkers, related therapies, clinical trials and guidelines. The results of this project will have important implications for medicine and public health.</div><div class="t-redactor__text"><strong>Methodology</strong>: We will use the available "National Laboratory Astana" collection of specimen and data of full genome sequencing of patients and healthy individuals recruited in the Republic of Kazakhstan. Amplicon sequencing using Oxford Nanopore Technologies (ONT). Bioinformatics methods using machine learning and molecular biology techniques.</div><div class="t-redactor__text"><strong>Contacts: </strong>ruslan.kalendar@nu.edu.kz</div>]]>
			</turbo:content>
		</item>
		<item turbo="true">
			<title>Chromosome-scale assembly of Kazakh individuals using modern genomics approaches</title>
			<link>https://nla.nu.edu.kz/tpost/1p4uv5v0p1-chromosome-scale-assembly-of-kazakh-indi</link>
			<amplink>https://nla.nu.edu.kz/tpost/1p4uv5v0p1-chromosome-scale-assembly-of-kazakh-indi?amp=true</amplink>
			<pubDate>Wed, 23 Jul 2025 10:08:00 +0300</pubDate>
			<description>AP23490594PI: Ulykbek Kairov</description>
			<turbo:content>
<![CDATA[<header><h1>Chromosome-scale assembly of Kazakh individuals using modern genomics approaches</h1></header><div class="t-redactor__text">Chromosome-scale assembly of Kazakh individuals using modern genomics approaches</div><div class="t-redactor__text">Project goal: Creation of a chromosomal-level assembly of whole genomes of individuals of the Kazakh population using data from long and short sequencing reads, as well as data from bionano optical genomic maps and Hi-C chromosomal conformation<br /><br />Project description: The idea of the project is to use genomic data obtained from modern high-throughput genomic platforms and bioinformatics methods to create the best chromosomal-level assembly of whole genomes of individuals of the Kazakh population and make it available for exploitation as a reference population-oriented genome in various biomedical investigations. <br /><br />Project facilitators: PI: Ulykbek Kairov;<br />Project participants: Asset Daniyarov, Askhat Molkenov, Kuanysh Sarkytbayev, Anel Ordabayeva.<br /><br />Realisation period: 2024-2026<br /><br />Expected results: - The quality of long and short sequencing reads will be assessed for subsequent de novo assembly of whole genomes;<br /><br />- De novo assembly of whole genomes of Kazakhstani individuals will be carried out based on data from long sequencing reads;<br /><br />- Integration of data from short sequencing reads will be carried out to polish and improve the assembly of whole genomes;<br /><br />- Hybrid integration of long-read assemblies with bionano genomic maps will be carried out to improve draft genomic assemblies;<br /><br />- Hi-C chromosomal conformation data will be mapped on the reference genome and hybrid genomic assemblies;<br /><br />- The quality of draft and hybrid genome assemblies will be assessed;<br /><br />- Comparative analysis of the resulting draft and hybrid assemblies will be carried out with genomic data from other populations and individuals;<br /><br />- The results of the best assemblies will be deposited in open access, making them available to use in comparative, population, and biomedical analysis by researchers in the field of genomics and bioinformatics;</div>]]>
			</turbo:content>
		</item>
	</channel>
</rss>